News

DISCOVER ALL THE RESEARCHERS REPATRIATED

Photo - Découvrez nos chercheurs rapatriés

Reverse the Brain Drain program

 

As part of this program, the Institut du cancer de Montréal implemented a major fundraising campaign, which led to the birth of the Concert contre le Cancer in 2009. Since its founding, the Concert contre le Cancer has raised a total of $4,139,189 net. Thanks to these funds, the Institut has been able to facilitate the return of researchers to Montreal by providing $250,000 in seed money to support them in the first five years. Since then, nine high-calibre researchers have been repatriated. Not only did these researchers come to the CRCHUM as part of the Institut du cancer de Montréal, they also brought their expertise on maximizing grants received through this program and standing out in provincial and national grant competitions. 

 

DISCOVER ALL THE RESEARCHERS REPATRIATED THROUGH THE CONCERT CONTRE LE CANCER 

 

  • Dr. Saima Hassan received her Ph.D. in Experimental Surgery from McGill University in 2009, after graduating from the Faculty of Medicine. Repatriated in 2016 from Oregon Health and Science University, USA, Dr. Hassan focuses on the role of PARP inhibitors for patients with triple-negative breast cancer.

 

  • Dr. Philip Wong received his diploma in radiation oncology in 2010 from McGill University. He was repatriated in 2014 from the CIHR Terry Fox Foundation, Toronto. He specializes in translational research on radiotherapy and sarcomas.

 

  • Dr. Simon Turcotte received his medical degree in 2003 and his master's degree in biomedical sciences from the Université de Montréal in 2008. He was repatriated in 2013 from the Memorial Sloan-Kettering Cancer Center, New York, USA. He specializes in immune recognition of gastrointestinal cancers.

 

  • Dr. Dominique Trudel received her Ph.D. in 2014 from the Université Laval. She was repatriated in 2013 from the University Health Network, Toronto. She specializes in diagnostic and prognostic applications of tissue and optic markers in prostate cancer.

 

  • Dr. John Stagg received his Ph.D. from McGill University. He was repatriated in 2010 from the Peter MacCallum Cancer Center, Melbourne, Australia. He specializes in the development of targeted cancer therapies based on the stimulation of the anti-tumor immune response.

 

  • Dr. Francis Rodier received his Ph.D. in 2005 from the Université de Montréal and was repatriated in 2009 from the Buck Institute for Research on Aging, California, USA. He specializes in exploring the relationship between cellular senescence, aging and cancer.

 

  • Dr. Jean-François Cailhier studied medicine at the Université de Montréal and received his Ph.D. from the University of Edinburgh, UK. He was repatriated in 2008 and specializes in the role of inflammatory and neoplastic microenvironments in the reprogramming of macrophages.

 

  • Dr. Jean-Baptiste Lattouf received his diploma in medicine from the Université de Montréal in 1999. He was repatriated in 2008 after completing his post-doctoral degree at the National Institutes of Health, Maryland, USA. He specializes in immunology, molecular biology and biomarkers in kidney cancer.

 

  • Dr. Estelle Schmitt received her Ph.D. from the Université de Montréal. She was repatriated in 2008 from the Paul Sabatier University, Toulouse, France. She specializes in epithelial ovarian cancer.